Inventor · disambiguated record
Justin Scheer
Also filed as: SCHEER JUSTIN · SCHEER JUSTIN M
33 granted patents·18 pending applications·141 citations·filing 2008–2024
96Inventor score
Top patents by PatentIndex Score
51 records- 0195US9815880B2IL-22 Fc fusion proteinsGENENTECH INC·Filed 2016·Granted Nov 14, 2017·15 cites·18 claims
- 0295US9637557B2Production of heteromultimeric proteinsSCHEER JUSTIN·Filed 2011·Granted May 2, 2017·58 cites·75 claims
- 0393US11332541B2Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2019·Granted May 17, 2022·8 cites·17 claims
- 0493US10626189B2Assembly of bispecific antibodiesGENENTECH INC·Filed 2017·Granted Apr 21, 2020·10 cites·27 claims
- 0592US12173083B2Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2022·Granted Dec 24, 2024·2 cites·18 claims
- 0691US10160793B2Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteinsGENENTECH INC·Filed 2014·Granted Dec 25, 2018·9 cites·30 claims
- 0790US10087227B2Nucleic acids encoding IL-22 Fc fusion proteinsGENENTECH INC·Filed 2016·Granted Oct 2, 2018·5 cites·26 claims
- 0889US9862778B2Assembly of bispecific antibodiesGENENTECH INC·Filed 2014·Granted Jan 9, 2018·8 cites·71 claims
- 0985US10407510B2Anti-factor D antibodies and conjugatesGENENTECH INC·Filed 2016·Granted Sep 10, 2019·10 cites·126 claims
- 1085US2024383984A1HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USEGENENTECH INC·Filed 2024·Application pending·0 cites
- 1183US2023357445A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1282US11725065B2Assembly of bispecific antibodiesGENENTECH INC·Filed 2020·Granted Aug 15, 2023·1 cites·20 claims
- 1381US11155591B2Methods of treating acute pancreatitis using IL-22 fc fusion proteinsGENENTECH INC·Filed 2018·Granted Oct 26, 2021·1 cites·27 claims
- 1481US8563839B2Methods of reducing leaf senescence using methyl dihydrojasmonateSCHEER BARBARA·Filed 2011·Granted Oct 22, 2013·4 cites·19 claims
- 1579US10323094B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2016·Granted Jun 18, 2019·2 cites·24 claims
- 1679US2024101714A1Assembly of bispecific antibodiesGENENTECH INC·Filed 2023·Application pending·0 cites
- 1778US10941190B2Production of heteromultimeric proteins using mammalian cellsGENENTECH INC·Filed 2016·Granted Mar 9, 2021·2 cites·12 claims
- 1878US2023063741A1IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USEGENENTECH INC·Filed 2022·Application pending·0 cites
- 1977US12030947B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2021·Granted Jul 9, 2024·0 cites·70 claims
- 2076US8013226B2Methods for reducing leaf senescence using methyl dihydrojasmonateNEW BIOLOGY INC·Filed 2009·Granted Sep 6, 2011·2 cites·9 claims
- 2175US2025026810A1Production of heteromultimeric proteins using mammalian cellsGENENTECH INC·Filed 2024·Application pending·0 cites
- 2274US2024158513A1FC Variants and Methods for Their ProductionGENENTECH INC·Filed 2024·Application pending·0 cites
- 2374US2025051460A1Bispecific anti-vegf and anti-trkb binding molecules for the treatment of eye diseasesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2473US9301524B2Methods for reducing leaf senescence using methyl dihydrojasmonateNEW BIOLOGY INC·Filed 2013·Granted Apr 5, 2016·1 cites·20 claims
- 2572US11192950B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2019·Granted Dec 7, 2021·0 cites·38 claims
- 2672US10961313B2Anti-factor D antibody variant conjugates and uses thereofGENENTECH INC·Filed 2019·Granted Mar 30, 2021·0 cites·41 claims
- 2772US2021171662A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2871US11332507B2IL-22 Fc fusion proteinsGENENTECH INC·Filed 2018·Granted May 17, 2022·0 cites·13 claims
- 2971US11130791B2Methods for treating metabolic syndrome using IL-22 Fc fusion proteinsGENENTECH INC·Filed 2018·Granted Sep 28, 2021·0 cites·29 claims
- 3071US2023340130A1Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 3169US11136365B2Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteinsGENENTECH INC·Filed 2018·Granted Oct 5, 2021·0 cites·28 claims
- 3269US10689447B2Fc variants and methods for their productionGENENTECH INC·Filed 2013·Granted Jun 23, 2020·1 cites·26 claims
- 3368US10179821B2Anti-factor D antibodiesGENENTECH INC·Filed 2015·Granted Jan 15, 2019·1 cites·9 claims
- 3468US2025136720A1Bispecific and tetravalent cd137 and fap molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3566US12030926B2Production of heteromultimeric proteins using mammalian cellsGENENTECH INC·Filed 2021·Granted Jul 9, 2024·0 cites·19 claims
- 3666US10584181B2Methods of making and using multispecific antibody panels and antibody analog panelsSCHEER JUSTIN·Filed 2010·Granted Mar 10, 2020·1 cites·30 claims
- 3765US10584155B2Pharmaceutical compositions of IL-22 Fc fusion proteinsGENENTECH INC·Filed 2017·Granted Mar 10, 2020·0 cites·29 claims
- 3864US12110335B2Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseasesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Oct 8, 2024·0 cites·15 claims
- 3964US10544198B2Methods of accelerating or improving wound healing using IL-22 FC fusion proteinsGENENTECH INC·Filed 2017·Granted Jan 28, 2020·0 cites·40 claims
- 4063US11912773B2Fc variants and methods for their productionGENENTECH INC·Filed 2020·Granted Feb 27, 2024·0 cites·35 claims
- 4163US2019185584A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2018·Application pending·0 cites
- 4261US2018282431A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2017·Application pending·0 cites
- 4360US11732045B2Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2020·Granted Aug 22, 2023·0 cites·20 claims
- 4457US12146000B2Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2021·Granted Nov 19, 2024·0 cites·48 claims
- 4553US2009133166A1Methods for Improving Flowering Characteristics Using Methyl DihydrojasmonateNEW BIOLOGY INC·Filed 2008·Application pending·0 cites
- 4653US2009082453A1Exogenous Methyl Dihydrojasmonate for Prevention and Control of Biotic Attack in PlantsNEW BIOLOGY INC·Filed 2008·Application pending·0 cites
- 4751US10654932B2Anti-factor D antibody variant conjugates and uses thereofGENENTECH INC·Filed 2016·Granted May 19, 2020·0 cites·41 claims
- 4849US2018355009A1IL-22 Fc FUSION PROTEIN AND METHODS OF USEGENENTECH INC·Filed 2018·Application pending·0 cites
- 4948US2015045219A1Abiotic and biotic stress tolerance peptides and polynucleotides, and compositions and methods comprising themNEW BIOLOGY INC·Filed 2014·Application pending·0 cites
- 5038US2018293360A1Systems and methods for predicting vitreal half-life of therapeutic agent-polymer conjugatesGENENTECH INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Justin Scheer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →